- Email: [email protected]
Exams 1 and 2
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:139 –141
CME ACTIVITIES Exams 1 and 2 Joseph C. Kolars, MD, Editor, CME Section
CME Credits: The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AGA Institute designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any relevant financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Instructions: Category 1 credit can be earned by reading the relevant articles and taking these CME examinations online at http://www.cghjournal. org/content/cme. Answers can be obtained online after completing the exam(s).
Objectives: Upon completion of these activities, participants should be able to demonstrate an increase in or affirmation of their knowledge of clinical medicine and evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
140
CME ACTIVITIES
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 5, No. 2
Effects of Proton-Pump Inhibitors on Functional Dyspepsia: A Meta-analysis of Randomized Placebo-Controlled Trials Wang WH, et al, Authors Test ID No.: 0027
Contact hours: 1.0
Expiration Date: February 29, 2008
Question 1: A 43-year-old woman presents with abdominal discomfort that is attributed to functional dyspepsia after a negative evaluation including esophagogastroduodenoscopy (EGD). She is told that use of a proton pump inhibitor (PPI) may help to improve her symptoms. She lacks prescription drug coverage and is on a limited budget. She would like a better understanding of what the actual benefit to her would be if she started the medication. Which of the following would be most accurate?
a. When compared with placebo, one a PPI for every 5 who are treated b. When compared with placebo, one a PPI for every 15 who are treated c. When compared with placebo, one a PPI for every 25 who are treated d. When compared with placebo, one a PPI for every 35 who are treated
person will benefit from person will benefit from person will benefit from person will benefit from
Question 2: The patient would like to know the meaning of “benefit.” Which definition of benefit was used most often in the metaanalysis reported by Wang et al?
a. b. c. d.
50% reduction in symptoms Fewer lost days from work Complete relief during the last few days of the study Sustained relief for 1 week following cessation of medication
a. b. c. d.
Pain often relieved by food Abdominal “fullness” Pain often relieved by belching Nausea
Question 3: The patient would like a better understanding of which symptoms are most likely to improve. Which of the following is most likely to respond to therapy?
Question 4: The patient would like to understand the dosing regimens and the benefit of standard dose therapy (eg, omeprazole 20 mg/d or lansoprazole 30 mg/d) vs high- or low-dose therapy. Which of the following statements would be most accurate?
a. Twice-daily dosing is more effective than once-daily dosing b. Every-other-day dosing is equivalent to daily dosing c. High-dose therapy is more effective than standard-dose therapy d. Low-dose therapy is equivalent to standard-dose therapy
CME ACTIVITIES Exams 1 and 2 Joseph C. Kolars, MD, Editor, CME Section
CME Credits: The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AGA Institute designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any relevant financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Instructions: Category 1 credit can be earned by reading the relevant articles and taking these CME examinations online at http://www.cghjournal. org/content/cme. Answers can be obtained online after completing the exam(s).
Objectives: Upon completion of these activities, participants should be able to demonstrate an increase in or affirmation of their knowledge of clinical medicine and evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
140
CME ACTIVITIES
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 5, No. 2
Effects of Proton-Pump Inhibitors on Functional Dyspepsia: A Meta-analysis of Randomized Placebo-Controlled Trials Wang WH, et al, Authors Test ID No.: 0027
Contact hours: 1.0
Expiration Date: February 29, 2008
Question 1: A 43-year-old woman presents with abdominal discomfort that is attributed to functional dyspepsia after a negative evaluation including esophagogastroduodenoscopy (EGD). She is told that use of a proton pump inhibitor (PPI) may help to improve her symptoms. She lacks prescription drug coverage and is on a limited budget. She would like a better understanding of what the actual benefit to her would be if she started the medication. Which of the following would be most accurate?
a. When compared with placebo, one a PPI for every 5 who are treated b. When compared with placebo, one a PPI for every 15 who are treated c. When compared with placebo, one a PPI for every 25 who are treated d. When compared with placebo, one a PPI for every 35 who are treated
person will benefit from person will benefit from person will benefit from person will benefit from
Question 2: The patient would like to know the meaning of “benefit.” Which definition of benefit was used most often in the metaanalysis reported by Wang et al?
a. b. c. d.
50% reduction in symptoms Fewer lost days from work Complete relief during the last few days of the study Sustained relief for 1 week following cessation of medication
a. b. c. d.
Pain often relieved by food Abdominal “fullness” Pain often relieved by belching Nausea
Question 3: The patient would like a better understanding of which symptoms are most likely to improve. Which of the following is most likely to respond to therapy?
Question 4: The patient would like to understand the dosing regimens and the benefit of standard dose therapy (eg, omeprazole 20 mg/d or lansoprazole 30 mg/d) vs high- or low-dose therapy. Which of the following statements would be most accurate?
a. Twice-daily dosing is more effective than once-daily dosing b. Every-other-day dosing is equivalent to daily dosing c. High-dose therapy is more effective than standard-dose therapy d. Low-dose therapy is equivalent to standard-dose therapy